Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Increased Global Gene Promoter Methylation after Relapse (Rel) of Acute Promyelocytic Leukemia (APL) from All- trans Retinoic Acid (ATRA)-Containing Treatment Is Dissociated from Concurrent Gene Expression Changes.

Da-Cheng Zhou, MD, PhD, Qingping Cui, PhD, Haesook Kim, PhD, Reid Thompson, BS, John Greally, MD, PhD, Eric E. Bouhassira, PhD, Robert E. Gallagher, MD

Blood (2007) 110 (11): 2121.

https://doi.org/10.1182/blood.V110.11.2121.2121

Published: 2007

Journal Articles

Treatment Type Determines Gene Expression Changes from Pretreatment (PTx) to Relapse (Rel) in Acute Promyelocytic Leukemia (APL).

Qingping Cui, PhD, Haesook Kim, PhD, Da-Cheng Zhou, MD,PhD, Peter H. Wiernik, MD, Martin S. Tallman, MD, Robert E. Gallagher, MD

Blood (2007) 110 (11): 3167.

https://doi.org/10.1182/blood.V110.11.3167.3167

Published: 2007

Journal Articles

Lack of Increased Gene Promoter Methylation at Relapse in Acute Promyelocytic Leukemia (APL).

Da-Cheng Zhou, MD,PhD, Reid Thompson, BS, Haesook Kim, PhD, John Greally, MD,PhD, Robert Gallagher, MD

Blood (2006) 108 (11): 4315.

https://doi.org/10.1182/blood.V108.11.4315.4315

Published: 2006

Journal Articles

Relapse of Acute Promyelocytic Leukemia (APL) Is Associated with Increased Methylation of the Retinoic Acid Receptor-Beta2 (RARβ2) Gene Promoter.

Da-Cheng Zhou, MD, PhD, Haesook Kim, PhD, Martin S. Tallman4, MD, Robert E. Gallagher, MD

Blood (2004) 104 (11): 1124.

https://doi.org/10.1182/blood.V104.11.1124.1124

Published: 2004

Journal Articles

Pyrosequencing Analysis of the Methylation Status of the CpG Island in the Retinoic Acid Receptor-β 2 (RAR-β 2 ) Gene Promoter.

Da-Cheng Zhou, MD, PhD, David Reynolds, Robert E. Gallagher, MD

Blood (2004) 104 (11): 4297.

https://doi.org/10.1182/blood.V104.11.4297.4297

Published: 2004

Journal Articles

Mutation of Cellular Retinoic Acid-Binding Protein-II (Crabp-II) Does Not Account for Resistance to All- Trans Retinoic Acid (ATRA) in Relapse Acute Promyelocytic Leukemia (APL).

Binu-John Sankoorikal, BS, Da-Cheng Zhou, MD, PhD, Peter H. Wiernik, MD, Robert E. Gallagher, MD

Blood (2004) 104 (11): 2081.

https://doi.org/10.1182/blood.V104.11.2081.2081

Published: 2004

NARROW

Increased Global Gene Promoter Methylation after Relapse (Rel) of Acute Promyelocytic Leukemia (APL) from All- trans Retinoic Acid (ATRA)-Containing Treatment Is Dissociated from Concurrent Gene Expression Changes.

Treatment Type Determines Gene Expression Changes from Pretreatment (PTx) to Relapse (Rel) in Acute Promyelocytic Leukemia (APL).

Lack of Increased Gene Promoter Methylation at Relapse in Acute Promyelocytic Leukemia (APL).

Relapse of Acute Promyelocytic Leukemia (APL) Is Associated with Increased Methylation of the Retinoic Acid Receptor-Beta2 (RARβ2) Gene Promoter.

Pyrosequencing Analysis of the Methylation Status of the CpG Island in the Retinoic Acid Receptor-β 2 (RAR-β 2 ) Gene Promoter.

Mutation of Cellular Retinoic Acid-Binding Protein-II (Crabp-II) Does Not Account for Resistance to All- Trans Retinoic Acid (ATRA) in Relapse Acute Promyelocytic Leukemia (APL).

Email alerts

ASH Publications

American Society of Hematology

Increased Global Gene Promoter Methylation after Relapse (Rel) of Acute Promyelocytic Leukemia (APL) from All- trans Retinoic Acid (ATRA)-Containing Treatment Is Dissociated from Concurrent Gene Expression Changes.

Treatment Type Determines Gene Expression Changes from Pretreatment (PTx) to Relapse (Rel) in Acute Promyelocytic Leukemia (APL).

Lack of Increased Gene Promoter Methylation at Relapse in Acute Promyelocytic Leukemia (APL).

Relapse of Acute Promyelocytic Leukemia (APL) Is Associated with Increased Methylation of the Retinoic Acid Receptor-Beta2 (RARβ2) Gene Promoter.

Pyrosequencing Analysis of the Methylation Status of the CpG Island in the Retinoic Acid Receptor-β 2 (RAR-β 2 ) Gene Promoter.

Mutation of Cellular Retinoic Acid-Binding Protein-II (Crabp-II) Does Not Account for Resistance to All- Trans Retinoic Acid (ATRA) in Relapse Acute Promyelocytic Leukemia (APL).

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only